Document:

HCR3 8K 062415 Exh. 10.1

EXHIBIT 10.1

REINSTATEMENT OF AND FIRST AMENDMENT TO ASSET PURCHASE 
AGREEMENT

THIS REINSTATEMENT OF AND FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT (this “Amendment”) is made and entered into effective as of the 24th day of June, 2015, by GAHC3 CHORUS SENIOR HOUSING PORTFOLIO, LLC, a Delaware limited liability company (“Buyer”), and CABA SH INVESTORS, LLC, a Virginia limited liability company, and CABA OPERATIONS, LLC, a Virginia limited liability company (individually and collectively, “Seller” or “Sellers”).

W I T N E S S E T H:

Buyer and Sellers entered into that certain Asset Purchase Agreement effective as of May 6, 2015 (the “Purchase Agreement”).  Buyer exercised its right under the Purchase Agreement to terminate same, and the parties now desire to reinstate and amend the Purchase Agreement.  Capitalized terms not defined herein shall have the meaning given to them in the Purchase Agreement.  Buyer and Sellers desire to amend the Purchase Agreement as herein set forth.

NOW, THEREFORE, for Ten and No/100 Dollars ($10.00) in hand paid and in consideration of the covenants and agreements herein contained, the adequacy and sufficiency of which are hereby acknowledged by the parties, the parties hereto mutually agree as follows:

1.Reinstatement of Purchase Agreement.  Seller and Purchaser hereby agree that the Purchase Agreement is hereby reinstated and shall continue in full force and effect as if Purchaser had not terminated the Purchase Agreement.

2.Loan Assumption.  Section 1.4(c) of the Purchase Agreement is hereby deleted and replaced in its entirety with the following:

(c)    Loan Assumption Approval; Purchaser Termination Right.  If Lender has not approved the Loan Assumption Request within one hundred eighty (180) days after the Date of Execution (the “Loan Assumption Approval Period”), then Purchaser shall have the unilateral and unconditional right to extend the Loan Assumption Approval Period by up to an additional ninety (90) days by delivering to Seller written notice of such election before the expiration of said original 180-day Loan Assumption Approval Period.  If Lender has not approved the Loan Assumption Request as of the expiration of the Loan Assumption Approval Period (as the same may be extended by the terms of this Section), then Purchaser shall elect one of the following: (1) to terminate the Purchase Agreement by delivering to Seller written notice of termination within five (5) Business Days after the expiration of the Loan Assumption Approval Period (as the same may be extended by the terms of this Section), and upon such termination Escrow Agent shall refund $250,000 of the Deposit to Seller and the balance of the Deposit to Purchaser, whereupon neither party shall have any liability or obligation to the other party than those of the Purchase Agreement which expressly survive a termination hereof; or (2) proceed with Closing, whereupon (A) the Loan Balance as of Closing will be paid from the Purchase Price otherwise payable to the Sellers pursuant to this Section 1.4, and the Facility shall be conveyed to Purchaser free and clear of any mortgage debt, and (B) any prepayment premium or similar penalty or fee related to the payment of the Loan Balance will be paid by Purchaser without deducting the same from the amount due to the Seller.  If Purchaser elects to extend the Loan Assumption Approval Period as provided in this Section and thereafter Purchaser fails to receive Lender’s approval of the Loan Assumption Request, and if such failure is the result of Purchaser having not exercised commercially reasonable efforts to obtain such approval, then Purchaser shall not have the right to terminate the Purchase Agreement pursuant to subclause (1) of the preceding sentence and instead shall be required to proceed pursuant to subclause (2) 

of the preceding sentence.  Purchaser shall be responsible for the payment of any fees, costs or expenses related to the Loan Assumption without deducting the same from the amount due to the Seller.

3.Conditions Precedent to Purchaser’s Obligation.  Section 8.6 of the Purchase Agreement states that, as a condition precedent to the obligation of Purchaser to effect the transactions contemplated by the Purchase Agreement, the average number of units/rooms occupied by Residents per day during the Test Period shall not be less than ninety-two percent (92%).  Notwithstanding the terms of said Section, if Purchaser elects to extend the Loan Assumption Approval Period as provided in Section 1.4(c) of the Purchase Agreement, then the Test Period for determining this condition shall be October 1, 2014 through September 30, 2015.    

4.Other Amendments. Through their respective counsel, Seller and Purchaser have agreed by exchange of email (a) to the form and substance of the Management Services Agreement to be executed at Closing, and the operating and capital budgets to be attached thereto, (b) to the form and substance of an Intellectual Property License Agreement to be executed at Closing, and (c) for Seller to cause the affiliated owner of a parcel located immediately adjacent to the Real Property to deliver to Purchaser at Closing a perpetual, non-exclusive easement, on customary and reasonable terms and conditions reasonably acceptable to Purchaser, granting Purchaser and its tenants, guests and invitees the right to utilize the parking areas on said parcel (which agreement will provide that the cost of maintaining the parking area shall be shared by the parcel owner and Purchaser. These agreements are hereby affirmed by Seller and Purchaser.

5.Full Force and Effect.  Except as specifically provided herein, the Purchase Agreement is unchanged and remains in full force and effect.

6.Counterparts; Facsimile Execution.  This Amendment may be executed in several counterparts, each of which shall be deemed to be an original, and all of which together shall constitute one and the same agreement.  This Amendment may be executed and delivered via telephonic or electronic facsimile or PDF transmission.

[Signatures on following page]

IN WITNESS WHEREOF, Sellers and Buyer have executed this Agreement effective as of the day and year first set forth above.

“SELLERS”
	
					
	CABA SH INVESTORS, LLC, a Virginia limited liability company 

By:  Smith/Packett Med-Com, LLC, 
Its Manager

	 
	 
	CABA OPERATIONS, LLC, a Virginia limited liability company

By:  Smith/Packett Med-Com, LLC, 
Its Manager

	By:
	/s/ HUNTER D. SMITH
	 
	By:
	/s/ HUNTER D. SMITH

	Name:
	Hunter D. Smith
	 
	Name:
	Hunter D. Smith

	Title:
	Vice Chairman Manager
	 
	Title:
	Vice Chairman Manager

[Signatures continue on following page]

	
			
	 
	“BUYER”
GAHC3 CHORUS SENIOR HOUSING PORTFOLIO, LLC, a Delaware limited liability company

By: Griffin-American Healthcare REIT III Holdings, LP, its Sole Member

By: Griffin-American Healthcare REIT III, Inc., its General Partner

	 

	By:
	/s/ DANNY PROSKY
	 

	Name:
	Danny Prosky
	 

	Title:
	President and Chief Operating OfficerEX-10.1

 Exhibit 10.1 

RECRO PHARMA, INC. 

AMENDED AND RESTATED EQUITY INCENTIVE PLAN 

1. Purpose. The Recro Pharma, Inc. Amended and Restated Equity Incentive
Plan1 is intended as an additional incentive to current and prospective employees, consultants and directors of the Company to enter into or remain in the service or employ of the Company or any
Affiliate and to devote themselves to the Company’s success, and to encourage the creation of shareholder value. Under the Plan, the Company may provide such persons with opportunities to acquire or increase their interests in the Company
through options to purchase the Company’s Common Stock, grants of stock appreciation rights and awards of the Company’s Common Stock. Under the Plan, the Company may grant (i) ISOs, (ii) Nonqualified Options, (iii) Stock
Appreciation Rights, (iv) Stock Awards, (v) Restricted Stock Awards and (vi) Restricted Stock Units. 
 2. Term of
Plan. The Plan was originally adopted by the Board of Directors on October 8, 2013, and is amended and restated as of April 1, 2015. No Option may be granted under the Plan after April 1, 2025. 

3. Definitions. Capitalized terms not otherwise defined in the Plan shall have the following meanings: 

“Affiliate” means a corporation which is a parent corporation or a subsidiary corporation with respect to the Company
within the meaning of section 424(e) or (f) of the Code. 
 “Award” means any Option, SAR, Restricted Stock or
Restricted Stock Unit granted pursuant to the terms of this Plan. 
 “Board” means the Board of Directors of the
Company. 
 “Cause” for termination of employment or service shall have the meaning ascribed thereto in the
Recipient’s employment or service agreement or, in the absence of such a definition, shall mean: 
 (i) Conviction of,
or agreement to a plea of nolo contendere to, a felony, or any crime or offense lesser than a felony involving the property of the Company or an Affiliate; 

(ii) Conduct that has caused demonstrable and serious injury to the Company or an Affiliate, monetary or otherwise; 

(iii) Willful refusal to perform or substantial disregard of duties properly assigned, as determined by the Board; 

(iv) Breach of duty of loyalty to the Company or an Affiliate or other act of fraud or dishonesty with respect to the Company
or an Affiliate; or 
 (v) Violation of the Company’s code of conduct. 

The definition of Cause set forth in the Recipient’s employment or service agreement with the Company or any of its Affiliates shall
control if such definition is different from the definition of Cause set forth herein. 
 “Code” means the Internal
Revenue Code of 1986, as amended from time to time, or any successor statute or statutes thereto. Reference to any particular section of the Code shall include any successor section. 

“Common Stock” means the Common Stock, par value $0.01, of the Company. 

“Company” means Recro Pharma, Inc., a Pennsylvania corporation. 

“Covered Employee” means a Recipient who is a Covered Employee as defined in Section 162(m) of the Code for the
tax year of the Company with regard to which a deduction in respect of such person’s Award would be allowed. 
  

 

	1 	The Recro Pharma, Inc. Amended and Restated Equity Incentive Plan amends and restates the Recro Pharma, Inc. 2013 Equity Incentive Plan. 

 “Disability” means, as determined by the Board, (a) the inability
to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that has lasted or can be expected to last for a continuous period of not less than 12
months or (b) Recipient’s becoming disabled within the meaning of section 22(e)(3) of the Code. 
 “Exchange
Act” means the Securities Exchange Act of 1934, as amended. 
 “Fair Market Value” of a share of Common Stock
on any day means the officially-quoted closing selling price of the stock on the principal securities exchange on which the Common Stock is then listed for trading (including for this purpose the NASDAQ Capital Market) for the applicable trading
day. 
 “Grant Date” means the effective date on which an Option is granted to an Optionee under the Plan. 

“ISO” means an Option granted under the Plan that is intended to qualify as an incentive stock option within the
meaning of section 422(b) of the Code. 
 “Nonqualified Option” means an Option granted under the Plan that is not
intended to qualify as an ISO. 
 “Option” means an option to purchase Common Stock granted under the Plan, which
may be designated as either an ISO or a Nonqualified Option. 
 “Option Documents” means written documents in such
form as approved from time to time by the Board, which shall be given to Optionees and shall set forth the terms and conditions of Options granted to Optionees under the Plan. 

“Optionee” means an employee, consultant or director to whom an Option is granted under the Plan. 

“Option Price” means the price at which Option Shares may be purchased under the terms of an Option. 

“Option Shares” means the shares of Common Stock that may be purchased by an Optionee upon exercise of an Option.

 “Performance Goals” means goals and objectives established by the Board, in its sole discretion, as
contingencies for Awards to vest and/or become exercisable or distributable based on such criteria and objectives as the Board may select from time to time, subject to the limitations of Section 162(m) of the Code, including, without
limitation, the performance of the Recipient, the Company, one or more of its Affiliates or divisions or any combination of the foregoing. 

“Plan” means the Recro Pharma, Inc. Amended and Restated Equity Incentive Plan. 

“Recipient” means an employee, consultant or director to whom an Option, Stock Award, Stock Appreciation Right,
Restricted Stock or Restricted Stock Unit is granted under the Plan. 
 “Restricted Stock Award” means a grant of
shares under this Plan that is subject to the restrictions under Section 8. 
 “Restricted Stock Unit” means a
contractual right underlying an Award granted under Section 8 that is denominated in shares, which unit represents a right to receive a share (or the value of a share) upon the terms and conditions set forth in the Plan and the applicable
Agreement. 
 “Retirement” means the date that the Recipient reaches age seventy (70). 

“SAR Shares” means the shares of Common Stock that may be issued in connection with the Company’s payment upon
the exercise of a Stock Appreciation Right. 
 “Separation from Service” means, with respect to a Recipient who is
an employee of the Company or an Affiliate, the termination of employment with the Company and all Affiliates that constitutes a “separation from service” within the meaning of Treas. Reg. § 1.409A-1(h)(1), (ii) with respect to a
Recipient who is a consultant of the Company or an Affiliate, the expiration of his contract or contracts under which services are performed that constitutes a “separation from service” within the meaning of

  
 2 

 
Treas. Reg. § 1.409A-1(h)(2), or (iii) with respect to a Recipient who is a non-employee director of the Company or an Affiliate, the date on which such non-employee director ceases to
be a member of the Board (or other applicable board of directors) for any reason. 
 “Stock Appreciation Right”
means a Recipient’s right to receive from the Company, in SAR Shares, cash or a combination thereof, an amount in excess, if any, of (i) if the Stock Appreciation Right is granted in connection with an Option, the Fair Market Value of such
Option Shares on the date of surrender of such Option Shares over the Option Price of such surrendered Option Shares, or (ii) if the Stock Appreciation Right is granted on a stand-alone basis, the Fair Market Value of the Common Stock on the
date of exercise over the initial basis of the Stock Appreciation Right as determined under the Stock Appreciation Right Agreement provided the initial basis shall be at least the Fair Market Value of the Common Stock on the date of grant. 

“Stock Appreciation Right Agreement” means the agreement between the Company and Recipient pursuant to which a Stock
Appreciation Right is granted. 
 “Stock Award” means the award of Common Stock granted to a Recipient under the
Plan. 
 “Stock Award Shares” means shares of Common Stock which are issued pursuant to a Stock Award under the
Plan. 
 4. Administration. The Plan shall be administered by a committee of Board members, which may consist of “outside
directors” as defined under section 162(m) of the Code, and related Treasury regulations, and “non-employee directors” as defined under Rule 16b-3 under the Exchange Act. However, the Board may ratify or approve any grants as it deems
appropriate, and the Board shall approve and administer all grants made to non-employee directors. To the extent that a committee or subcommittee administers the Plan, references in the Plan to the “Board” shall be deemed to refer to the
committee or subcommittee. 
 The Board shall from time to time at its discretion grant Awards pursuant to the terms of the Plan. The Board
shall have plenary authority to determine the Recipients to whom and the times at which Awards shall be granted, and the form and substance of Awards made under the Plan to each Recipient, and the conditions and restrictions, if any, subject to
which such Awards will be made (which need not be identical for all Recipients) thereof, subject, however, to the express provisions of the Plan. In making such determinations the Board may take into account the nature of the Recipient’s
services and responsibilities, the Recipient’s present and potential contribution to the Company’s success and such other factors as it may deem relevant. The interpretation and construction by the Board of any provision of the Plan or of
any Award granted under it shall be final, binding and conclusive. Notwithstanding the foregoing, the Board shall not take any of the following actions without shareholder approval, except as provided in Section 12: (i) reduce the exercise
price following the grant of an Option or SAR; (ii) exchange an Option or SAR which has an exercise price that is greater than the Fair Market Value of a Share for cash or Shares; or (iii) cancel an Option or SAR in exchange for a
replacement option or another Award with a lower exercise price. 
 No member of the Board shall be personally liable for any action or
determination made in good faith with respect to the Plan or any Award granted under it. No member of the Board shall be liable for any act or omission of any other member of the Board or for any act or omission on his own part, including but not
limited to the exercise of any power and discretion given to him under the Plan, except those resulting from (i) any breach of such member’s duty of loyalty to the Company or its shareholders, (ii) acts or omissions not in good faith
or involving intentional misconduct or a knowing violation of law, and (iii) any transaction from which the member derived an improper personal benefit. 

In addition to such other rights of indemnification as he may have as a member of the Board, and with respect to the administration of the
Plan and the granting of Awards under it, each member of the Board shall be entitled without further action on his part to indemnification from the Company for all expenses (including the amount of any judgment and the amount of any approved
settlement made with a view to the curtailment of costs 

  
 3 

 
of litigation, other than amounts paid to the Company itself) reasonably incurred by him in connection with or arising out of any action, suit or proceeding with respect to the administration of
the Plan or the granting of Awards under it in which he may be involved by reason of his being or having been a member of the Board, whether or not he continues to be such member of the Board at the time of the incurring of such expenses; provided,
however, that such indemnification shall not include any expenses incurred by such member of the Board: (i) in respect of matters as to which he shall be finally adjudged in such action, suit or proceeding to have been guilty of gross
negligence or willful misconduct in the performance of his duties as a member of the Board; or (ii) in respect of any matter in which any settlement is effected in an amount in excess of the amount approved by the Company on the advice of its
legal counsel; and provided further that no right of indemnification under the provisions set forth herein shall be available to or accessible by any such member of the Board unless within five days after institution of any such action, suit or
proceeding he shall have offered the Company in writing the opportunity to handle and defend such action, suit or proceeding at its own expense. The foregoing right of indemnification shall inure to the benefit of the heirs, executors or
administrators of each such member of the Board and shall be in addition to all other rights to which such member of the Board would be entitled to as a matter of law, contract or otherwise. 

5. Eligibility. All employees of the Company or its subsidiary Affiliates (who may also be officers or directors of the Company
or its Affiliates) shall be eligible to receive Stock Awards, Stock Appreciation Rights, Restricted Stock Awards or Restricted Stock Units and Options hereunder, and such Options may be either ISOs or Nonqualified Options. All non-employee directors
of the Company and all consultants or advisory board members providing services to the Company shall be eligible to receive Nonqualified Options, Stock Appreciation Rights, Stock Awards, Restricted Stock Awards and Restricted Stock Units hereunder.
All employees of the Company’s parent Affiliates (who may also be officers of the parent Affiliate) shall be eligible to receive grants of Stock Awards.) The Board, in its sole discretion, shall determine whether an individual qualifies as an
employee, consultant or Recipient. A Recipient may receive more than one Award of Options, Stock Appreciation Rights, Stock Awards, Restricted Stock or Restricted Stock Units. No member of the Board shall vote as a member of the Board with respect
to the grant of any Award to himself or herself, except in the case when grants are being made to all similarly situated Board members on the same terms and conditions. In cases in which abstention is required by the foregoing sentence, the
affirmative vote of a majority of the remaining members of the Board (or of the sole remaining member of the Board) shall constitute the action of the Board. 

6. Shares Available for Awards. Except as provided in Section 12, the aggregate maximum number of shares of Common Stock
(the “Shares”) that may be issued pursuant to the Plan is Two Million (2,000,000) (the “Reserved Shares”). On the 1st of December of each year, beginning in 2015, the
number of Reserved Shares may be increased by the Board, without the necessity of further approval from the Shareholders, by an amount not greater than five percent (5%) of the Company’s issued and outstanding capital stock, or such lower
amount as determined by the Board in its sole discretion. Such Shares may be in whole or in part authorized and unissued or held by the Company as treasury shares. If any grant under the Plan expires, lapses, terminates unexercised, becomes
unexercisable or is forfeited as to any Shares, or is tendered or withheld as to any Shares in payment of the exercise price of the grant or the taxes payable with respect to the exercise, then such unpurchased, forfeited, tendered or withheld
Shares shall thereafter be available for further grants under the Plan unless, in the case of Options granted under the Plan, related SARs are exercised. 

With respect to SARs that are settled in Common Stock, upon settlement, only the number of shares of Common Stock delivered to a Recipient
upon the exercise of the SARs shall count against the number of Shares issued under the Plan. Any Award under the Plan settled in cash shall not be counted against the foregoing maximum share limitations. 

Shares issued under Awards granted in assumption, substitution or exchange for previously granted awards of a company acquired by the Company
(“Substitute Awards”) shall not reduce Shares available under Plan. Available shares under a shareholder approved plan of an acquired company (as appropriately adjusted to reflect such acquisition) may be used for Awards under this Plan
and shall not reduce the number of Shares available under this Plan, except as required by the rules of any applicable stock exchange. 

  
 4 

 To the extent required by Section 162(m) of the Code for Awards under the Plan to qualify as
“performance-based compensation,” the following individual Recipient limitations shall apply: 
 The maximum number of shares of
Common Stock subject to any Award for which the grant of such Award is subject to the attainment of Performance Goals in accordance with Section 8, which may be granted under this Plan during any fiscal year of the Company to each Recipient
shall be 400,000 shares per type of Award (which shall be subject to any further increase or decrease pursuant to Section 12), provided that the maximum number of shares of Common Stock for all types of Awards does not exceed 1,000,000
(which shall be subject to any further increase or decrease pursuant to Section 12) during any fiscal year of the Company. 
 There are
no annual individual Recipient share limitations on Restricted Stock for which the grant of such Award is not subject to attainment of Performance Goals in accordance with Section 8. 

The individual Recipient limitations set forth in this Section 6 shall be cumulative; that is, to the extent that shares of Common Stock
for which Awards are permitted to be granted to a Recipient during a fiscal year are not covered by an Award to such Recipient in a fiscal year, the number of shares of Common Stock available for Awards to such Recipient shall automatically increase
in the subsequent fiscal years during the term of the Plan until used. 
 Without limiting the generality of the foregoing provisions of
this Section 6 or any other section of this Plan, the Committee may, at any time or from time to time, and on such terms and conditions (that are consistent with and not in contravention of the other provisions of this Plan) as the Committee
may determine, take other actions with respect to the Awards or new Awards containing terms (including, without limitation, exercise prices) more (or less) favorable than the then-outstanding Awards. 

7. Option Shares, SAR Shares and Stock Award Shares. Options granted pursuant to the Plan shall be evidenced by Option Documents
in such form as the Board shall from time to time approve, which Option Documents shall specify whether the Option is intended to be an ISO or a Nonqualified Option for federal income tax purposes. An Option shall only be an ISO to the extent it
does not exceed the limitation set forth in subsection 7(c) below, is described as an ISO in the Option Document, and is granted to a person who is an employee of the Company or an Affiliate on the Grant Date. All Option Documents shall comply with
and be subject to the following terms and conditions and with any other terms and conditions (including vesting schedules for the exercisability of Options) the Board shall from time to time provide that are not inconsistent with the terms of the
Plan. 
 (a) Option Price. Each Option Document shall state the “Option Price” at which Option Shares may be
purchased, which in no event shall be less than the Fair Market Value of the Common Stock on the Grant Date, provided, however, that if an ISO is granted to an Optionee who then owns, directly or by attribution under section 424(b) of the Code,
shares possessing more than ten percent of the total combined voting power of all classes of stock of the Company or an Affiliate, then the Option Price shall be at least 110% of the Fair Market Value of the Option Shares on the Grant Date. 

(b) Medium of Payment. An Option shall be exercised by written notice to the Company upon such terms and conditions as the
Option Document may provide and in accordance with such other procedures for the exercise of Options as the Board may establish from time to time. The method or methods of payment of the Option Price to be paid upon exercise of an Option shall be
determined by the Board and set forth in the Option Document, and may consist of (i) cash, (ii) certified check payable to the order of the Company, (iii) payment through a broker in accordance with procedures permitted by Regulation
T of the Federal Reserve Board, (iv) shares of Common Stock previously acquired by the Optionee, as permitted in the discretion of the Board, (v) reduction in the number of shares of Common Stock otherwise deliverable upon exercise of the
Option with a Fair Market Value equal to the aggregate Option Price at the time of exercise (a so-called “cashless exercise”), or (vi) such other mode of payment as permitted for the issuance of shares under the Pennsylvania Business

  
 5 

 
Corporation Law, as amended, and approved by the Board, or any combination of the foregoing methods of payment. Payment of the Option Price by a method other than cash shall be subject to such
restrictions and limitations as set forth in the Option Document. 
 (c) Number of Option Shares. Each Option Document shall
state the number of Option Shares to which it pertains. In no event shall the aggregate Fair Market Value of the Option Shares (determined on the Grant Date) with respect to which an ISO is exercisable for the first time by the Optionee during any
calendar year (under all incentive equity plans of the Company or its Affiliates) exceed $100,000. 
 (d) Issuance of Option
Shares. Subject to the provisions of this Section 7, the Company shall effect the issuance of Option Shares purchased under an Option as soon as practicable after the exercise thereof, payment of the Option Price thereof and compliance
with any requirements for the withholding of income taxes. No Recipient or other person exercising an Option shall have any of the rights of a shareholder of the Company with respect to Option Shares purchased as a result of such exercise until due
exercise and full payment has been made and the requirements of Section 7 have been satisfied. No adjustment shall be made for cash dividends or other rights for which the record date is prior to the date of such due exercise and full payment.
No Option shall be deemed to have been exercised prior to the receipt by the Company of written notice of such exercise and of payment in full of the Option Price for the Option Shares to be purchased. Each such notice shall specify the number of
Option Shares to be purchased. 
 (e) Termination of Options. No Option shall be exercisable after the first to occur of the
following: 
 (i) Expiration of the Option term specified in the Option Document, which shall not exceed ten years from the date of grant
(or, in the case of an ISO, five years from the date of grant if, on such date the Optionee owns, directly or by attribution under section 424(b) of the Code, shares possessing more than ten percent (10%) of the total combined voting power of
all classes of stock of the Company or an Affiliate). 
 (ii) Expiration of one year from the date the Optionee’s employment with the
Company or its Affiliates terminates by reason of the Optionee’s Disability or death. 
 (iii) Expiration of three months (or such
shorter period as the Board may select) from the date the Optionee’s employment with the Company or its Affiliates terminates, unless such termination was due to Disability, death or termination for Cause. 

(iv) Immediately upon the date the Optionee’s employment or service with the Company or its Affiliates terminates, if the Board finds,
after full consideration of the facts presented on behalf of both the Company and the Optionee, that the Optionee has been discharged from employment or service with the Company or an Affiliate for Cause. In the event of a finding that the Optionee
has been discharged for Cause, in addition to immediate termination of the Option, the Optionee shall automatically forfeit all Option Shares for which the Company has not yet delivered the share certificates upon refund of the Option Price. 

(v) The date, if any, set by the Board under terms specified in an Option Document to be an accelerated expiration date in the event of a
“Change in Control” (as defined in Section 9 below), provided an Optionee who holds an Option is given written notice at least 30 days before the date so fixed. 

(f) Extension of Time to Exercise. The Board may, if it determines that to do so would be in the Company’s best interests,
provide in a specific case or cases to extend the period of time that a Nonqualified Option may be exercised by Optionee whose employment with the Company and its Affiliates has terminated, provided that the time to exercise an Option shall in no
event be extended beyond the original term of the Option as set forth in subsection 7(e)(i). 
 (g) Sale or Reorganization. If
the Company is merged or consolidated with another corporation, or if the property or stock of the Company is acquired by another corporation, and if the Options are not accelerated as 

  
 6 

 
provided in subsection 7(e) above, the Board shall be authorized to substitute the Options issued under the Plan with options to acquire stock of the merged, consolidated or acquiring
corporation, which substitution of options shall comply with the requirements of sections 424(a) and 409A of the Code. 
 (h)
Transfers. No ISO granted under the Plan may be transferred, except by will or by the laws of descent and distribution. During the lifetime of the Optionee, such ISO may be exercised only by him. 

(i) Other Provisions. The Option Documents shall contain such other provisions including, without limitation, additional
restrictions upon the exercise of the Option or additional limitations upon the term of the Option, as the Board shall deem advisable. 

(j) Amendment. Subject to the provisions of the Plan, the Board shall have the right to amend Option Documents issued to
Optionee, subject to the Optionee’s consent if such amendment is not favorable to the Optionee, except that the consent of the Optionee shall not be required for any amendment made under Section 12. 

8. Restricted Stock and Restricted Stock Units. The Awards granted under this Section 8 are subject to such restrictions as
the Board may impose (including, without limitation, any limitation on the right to vote shares underlying Restricted Stock Units or the right to receive any dividend, other right or property), which restrictions may lapse separately or in
combination at such time or times, in such installments or otherwise, as the Board may deem appropriate. Such Awards will be evidenced by an agreement containing the terms of the Awards, including, but not limited to: (i) the number of shares
of Restricted Stock or Restricted Stock Units subject to such Award; (ii) the purchase price, if any, of the shares of Restricted Stock or Restricted Stock Units and the means of payment for the shares of Restricted Stock or Restricted Stock
Units; (iii) the Performance Goals, if any, and level of achievement in relation to the Performance Goals that shall determine the number of shares of Restricted Stock or Restricted Stock Units granted, issued, retainable and/or vested;
provided, however, that any such Performance Goals shall comply with Section 162(m) of the Code; (iv) such terms and conditions of the grant, issuance, vesting and/or forfeiture of the Restricted Stock or Restricted Stock Units as may be
determined from time to time by the Board; (v) restrictions on transferability of the Restricted Stock or Restricted Stock Units; and (vi) such further terms and conditions, in each case, not inconsistent with this Plan as may be
determined from time to time by the Board. Such Performance Goals may incorporate, if and only to the extent permitted under Section 162(m) of the Code, provisions for disregarding (or adjusting for) changes in accounting methods, corporate
transactions (including, without limitation, dispositions and acquisitions) and other similar type events or circumstances. To the extent any such provision would create impermissible discretion under Section 162(m) of the Code or otherwise
violate Section 162(m) of the Code, such provision shall be of no force or effect. 
 (a) Without limiting the foregoing, and except as
otherwise revised in the Award agreement documenting a service-based Restricted Stock Unit Award (“RSUs”), the following general rules will apply to outstanding RSUs at the time of Separation from Service: 

(i) In the event of Separation from Service for Cause, all outstanding RSUs will immediately terminate and be forfeited. 

(ii) In the event of Separation from Service due to death or Retirement of the Recipient while employed by the Company or any of its
Affiliates, or the termination of service of the Recipient due to Disability (whether or not a Separation from Service), then an amount of unvested RSUs shall vest equal to a percentage, the numerator of which equals the number of days that has
elapsed as of the date of death or Retirement or the date on which such Disability commenced (such date to be determined by the Board in its sole discretion) in the vesting restriction period for each applicable vesting tranche, and the denominator
of which equals the total number of days in each such vesting restriction period, rounded down to the nearest whole Share. All vested RSUs will be paid in accordance with the payment provisions set forth in this Plan. 

  
 7 

 (iii) In all other events of Separation from Service, to the extent not previously paid, the
Recipient shall be paid any vested RSUs in accordance with the payment provisions of Section 8(c), and all unvested RSUs shall immediately terminate and be forfeited. 

(b) Any Award of Restricted Stock or Restricted Stock Units may be evidenced in such manner as the Board may deem appropriate, including,
without limitation, book-entry registration or issuance of a stock certificate or certificates. In the event any stock certificate is issued in respect of shares underlying a Restricted Stock Award, such certificate will be registered in the name of
the Recipient and bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such shares. 
 (c)
Restricted Stock and Restricted Stock Unit Awards shall (subject to satisfaction of any purchase price requirement) be transferred or paid to the Recipient as soon as practicable following the Award date or the termination of the vesting or other
restrictions set forth in the Plan or the Award and the satisfaction of any and all other conditions of the Award applicable to such Restricted Stock or Restricted Stock Unit Award (the “Restriction End Date”), but in no event later than
two and one-half (2 1⁄2) months following the end of the calendar year that includes the later of the Award date or the Restriction End Date, as the case
may be. In the event a Recipient terminates service with the Company due to a Disability, then the Recipient’s vested Restricted Stock Units shall be paid to the Recipient within thirty (30) days of the Board’s determination of
Disability. Notwithstanding any of the foregoing, to the extent that the provisions of any Award for Restricted Stock Units require, distributions of stock under circumstances that constitute a “deferral of compensation” shall conform to
the applicable requirements of Section 409A of the Code, including, without limitation, the requirement that a distribution to a Recipient who is a “specified employee” within the meaning of Section 409A(a)(2)(B)(i) which is made
on account of the specified employee’s Separation from Service shall not be made before the date which is six (6) months after the date of Separation from Service. 

9. Change of Control. Unless otherwise provided in a Recipient’s employment or service agreement, in the event of a Change
in Control (as defined below), the Board may take whatever action with respect to the Options outstanding it deems necessary or desirable, including, without limitation, accelerating the vesting, as well as expiration or termination date in the
respective Option Documents. If Options granted pursuant to the Plan are accelerated, such Options shall become immediately exercisable in full. 

(a) Unless otherwise defined in a Recipient’s employment agreement, a “Change of Control” shall be deemed to have occurred upon
the happening of any of the following events: 
 (i) Any “person” (as that term is used in Sections 13 and 14(d)(2) of the
Exchange Act or any successors thereto) becomes the “beneficial owner” (as that term is used in Section 13(d) of the Exchange Act or any successor thereto), directly or indirectly, of 50% or more of the Company’s capital stock
entitled to vote in the election of directors, excluding any “person” who becomes a “beneficial owner” in connection with a Business Combination (as defined in paragraph (iii) below) which does not constitute a Change in
Control under said paragraph (iii); 
 (ii) Persons who on the effective date of the plan of reorganization of the Company (the
“Commencement Date”) constitute the Board (the “Incumbent Directors”) cease for any reason, including without limitation, as a result of a tender offer, proxy contest, merger or similar transaction, to constitute at
least a majority thereof; provided that, any person becoming a director of the Company subsequent to the Commencement Date shall be considered an Incumbent Director if such person’s election or nomination for election was approved by a vote of
at least two-thirds (2/3) of the Incumbent Directors; but provided further that, any such person whose initial assumption of office is in connection with an actual or threatened election contest relating to the election of members of the Board
or other actual or threatened solicitation of proxies or consents by or on behalf of a “person” (as defined in Sections 13(d) and 14(d) of the Exchange Act) other than the Board, including by reason of agreement intended to avoid or settle
any such actual or threatened contest or solicitation, shall not be considered an Incumbent Director; 

  
 8 

 (iii) Consummation of a reorganization, merger or consolidation or sale or other disposition of
all or substantially all of the assets of the Company (a “Business Combination”), in each case, unless, following such Business Combination, all or substantially all of the individuals and entities who were the beneficial owners of
outstanding voting securities of the Company immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the combined voting power of the then outstanding voting securities entitled to vote generally in
the election of directors, as the case may be, of the company resulting from such Business Combination (including, without limitation, a company which, as a result of such transaction, owns the Company or all or substantially all of the
Company’s assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership, immediately prior to such Business Combination, of the outstanding voting securities of the Company; or 

(iv) The shareholders of the Company approve any plan or proposal for the liquidation or dissolution of the Company. 

In addition, with respect to any Award that is characterized as “nonqualified deferred compensation” within the meaning of Section 409A of the
Code, an event shall not be considered to be a Change in Control under the Plan for purposes of payment of such Award unless such event is also a “change in ownership,” a “change in effective control” or a change in ownership of
a substantial portion of the assets” of the Company within the meaning of Section 409A of the Code. 
 10. Grant of Stock
Appreciation Rights. 
 (a) General. The Board shall have authority to grant Stock Appreciation Rights under the Plan.
Subject to the satisfaction in full of any conditions, restrictions or limitations imposed in accordance with the Plan or any Stock Appreciation Right Agreement, a Stock Appreciation Right shall entitle the Recipient to surrender to the Company the
Stock Appreciation Right in exchange for SAR Shares, cash or a combination thereof as herein provided, in the amount described in Section 10(c)(ii) hereof. 

(b) Grant. Stock Appreciation Rights may be granted in conjunction with all or part of any Option granted under the Plan
(“Tandem SARs”), in which case the exercise of the Stock Appreciation Right shall require the cancellation of a corresponding portion of the Option, and the exercise of an Option shall result in the cancellation of a corresponding portion
of the Stock Appreciation Right. In the case of an Nonqualified Stock Option, Tandem SARs may be granted either at or after the time of grant of such Option and provided the SAR satisfies conditions under Treas. Reg. § 1.422-5(d)(3). In the
case of an ISO, Tandem SARs may be granted only at the time of grant of such Option. A Stock Appreciation Right may also be granted on a stand-alone basis. The grant of a Stock Appreciation Right shall occur as of the date the Board determines. Each
Stock Appreciation Right granted under this Plan shall be evidenced by a Stock Appreciation Right Agreement, which shall embody the terms and conditions of such Stock Appreciation Right and which shall be subject to the terms and conditions set
forth in this Plan. 
 (c) Terms and Conditions. Stock Appreciation Rights shall be subject to such terms and conditions as
shall be determined by the Board, including the following: 
 (i) Period and Exercise. The term of a Stock Appreciation Right
shall be established by the Board. If granted in conjunction with an Option, such Tandem SAR shall have a term which is the same as the term for the Option and shall be exercisable only at such time or times and to the extent the related Options
would be exercisable in accordance with the provisions of Section 7 of the Plan. A Stock Appreciation Right which is granted on a stand-alone basis shall be for such period and shall be exercisable at such times and to the extent provided in
the Stock Appreciation Right Agreement. Stock Appreciation Rights shall be exercised by the Recipient’s giving written notice of exercise in form satisfactory to the Company specifying the portion of the Stock Appreciation Right to be
exercised. 

  
 9 

 (ii) Amount. Upon the exercise of a Tandem SAR, a Recipient shall be entitled to
receive an amount in cash, SAR Shares or both as determined by the Board or as otherwise permitted in the Stock Appreciation Right Agreement, equal in value to the excess of the Fair Market Value per share of an Option Share at the exercise date
over the Option Price of such Option Shares multiplied by the number of Option Shares in respect of which the Stock Appreciation Right is exercised. In the case of a Stock Appreciation Right granted on a stand-alone basis, the Recipient shall be
entitled to receive an amount in cash, SAR Shares or both as determined by the Board or as otherwise permitted in the Stock Appreciation Right Agreement, equal to the value in excess of the Fair Market Value of the Common Stock on the date of
exercise of the Stock Appreciation Right over the initial basis of the Stock Appreciation Right as set forth in the Stock Appreciation Agreement which shall be at least the Fair Market Value of the Common Stock on the date of grant. 

(iii) Non-transferability of Stock Appreciation Rights. Tandem SARs shall be transferable only when and to the extent that the
related Option would be transferable under the Plan unless otherwise provided in an Agreement. No other Stock Appreciation Rights granted hereunder may be other than by will, the laws of descent and distribution, or pursuant to a qualified domestic
relations order. 
 (iv) Termination. Tandem SARs shall terminate at such time as the related Option would terminate under
the Plan, unless otherwise provided in an Agreement as to a Nonqualified Option. All other Stock Appreciation Rights shall terminate as provided in the Stock Appreciation Right Agreement. No Stock Appreciation Right shall terminate more than ten
years from the Grant Date. 
 (v) Incentive Stock Option. A Stock Appreciation Right granted in tandem with an ISO shall not
be exercisable unless the Fair Market Value of the Common Stock on the date of exercise exceeds the Option Price. In no event shall any amount paid pursuant to the Stock Appreciation Right exceed the difference between the Fair Market Value on the
date of exercise and the Option Price. 
 11. Grant of Stock Awards. Stock Awards will consist of shares of Common Stock
transferred to Recipients, without payment or other consideration therefor. Stock Awards shall be subject to such terms and conditions as the Board determines appropriate, including without limitation, restrictions on sale or other disposition of
such Stock Award Shares, and the rights of the Company to reacquire such Stock Award Shares upon termination of Recipients employment with the Company within specified periods, whether for Cause or otherwise. 

12. Adjustments on Changes in Common Stock. In the event that any reorganization, recapitalization, stock split, reverse stock
split, stock dividend, combination of shares, merger, consolidation, distribution of assets, or any other change in the corporate structure or shares of the Company affects Shares such that an adjustment is appropriate in order to prevent dilution
or enlargement of the rights of Recipients under the Plan, the Board shall make such equitable adjustments in any or all of the following in order to prevent such dilution or enlargement of rights: the number and kind of Shares or other property
available for issuance under the Plan (including, without limitation, the total number of Shares available for issuance under the Plan pursuant to Section 6), the number and kind of Awards or other property covered by Awards previously made
under the Plan, and the exercise price of outstanding Options and SARs. Any such adjustment shall be final, conclusive and binding for all purposes of the Plan provided that no adjustment shall be made which will cause an ISO to lose its status as
such or will cause any Option or Stock Appreciation Right to lose its status as exempt from Code Section 409A. Any adjustments made under this Section 12 shall be made in a manner which does not adversely affect the exemption provided
pursuant to Rule 16b-3 under the Exchange Act. In the event of any merger, consolidation or other reorganization in which the Company is not the surviving or continuing corporation or in which a Change in Control is to occur, all of the
Company’s obligations regarding any Awards that were granted hereunder and that are outstanding on the date of such event shall, on such terms as may be approved by the Committee prior to such event, be assumed by the surviving or continuing
corporation or canceled in exchange for property (including cash). 

  
 10 

 13. Amendment of the Plan. The Board may amend the Plan from time to time in such
manner as it may deem advisable. Notwithstanding the foregoing, any amendment which would change the class of individuals eligible to receive an Award, extend the expiration date of the Plan, or increase the maximum aggregate number of shares of
Common Stock available for issuance under the Plan will only be effective if such action is approved by a majority of the outstanding voting stock of the Company within twelve months before or after such action. 

14. Continued Employment. The grant of an Award pursuant to the Plan shall not be construed to imply or to constitute evidence
of any agreement, express or implied, on the part of the Company or any Affiliate to retain the Recipient in the employ of the Company or an Affiliate, as a member of the Board, as an independent contractor or in any other capacity, whichever the
case may be. 
 15. Withholding of Taxes. Whenever the Company proposes or is required to issue or transfer an Award, the
Company shall have the right to (a) require the recipient or transferee to remit to the Company an amount sufficient to satisfy any federal, state and/or local withholding tax requirements prior to the delivery or transfer of any certificate or
certificates for such Award or (b) take whatever action it deems necessary to protect its interests, including the right to deduct the amount required to be withheld from any payment of any kind otherwise due to the Recipient. If and to the
extent permitted by the Board, a Recipient may satisfy applicable withholding requirements by the delivery to the Company of previously held shares of Common Stock or the withholding of Awards otherwise issuable to the Recipient. 

16. General.  

(a) Effective Date. This Incentive Equity Plan shall be effective as of the date specified in Section 2. 

(b) Other Plans. The adoption of the Plan shall not be construed as creating any limitations on the power of the Board to adopt
such other incentive arrangements as it may deem desirable, including without limitation the awarding of stock options otherwise than under the Plan. Unless otherwise provided by the Board in an Option Document or in a written agreement between the
Recipient and the Company or an Affiliate except as may otherwise be provided for under a pension or welfare benefit plan subject to ERISA, the amounts deemed paid to a Recipient under the Plan shall not be taken into account, in any manner, as
salary, compensation or bonus in determining the amount of any payment under any pension, retirement, or other employee benefit plan, program or policy of the Company or any Affiliate. 

(d) Governing Law. The validity, construction, interpretation and effect of the Plan and Option Documents, Stock Appreciation
Right Agreements and Stock Awards issued under the Plan shall be governed and construed by and determined in accordance with the laws of the Commonwealth of Pennsylvania, without giving effect to the conflict of laws provisions thereof. 

17. Compliance with 409A and ISO Requirements. 

(a) Exemption from and Compliance with 409A. The Board shall administer, construe, and interpret the Plan, and exercise its
authority and discretion, so that all Options, Stock Appreciation Rights, Stock Awards, Restricted Stock or Restricted Stock Units granted under the Plan satisfy the requirements for an exemption from or comply with Code Section 409A and that
Options intended to be ISOs are eligible for that tax treatment. Notwithstanding any provision of this Plan to the contrary, all rights under this Plan shall be designed and administered to be exempt from Section 409A of the Code. To the extent
that the Board or any governmental agency determines that any rights hereunder are subject to Section 409A of the Code, this Plan shall incorporate (or shall be amended to incorporate) the terms and conditions necessary to avoid the
consequences specified in Section 409A(a)(1) of the Code. 

  
 11 

 (b) Contemplated Amendments. It is expressly contemplated that the Board may amend
the Plan, any Option Document, any Stock Appreciation Right Agreement, or terms of any Stock Award or Restricted Stock Unit in any respect the Board deems necessary or advisable to provide the Recipient with the maximum benefits provided or to be
provided under the provisions of the Code and the regulations promulgated thereunder relating to ISOs or to avoid additional income taxes and other consequences arising from nonqualified deferred compensation that is not exempt from or that does not
comply with Code Section 409A and/or to bring the Plan and/or the Option, Stock Appreciation Right, Stock Award or Restricted Stock Unit granted under it into compliance with or qualification for exemption from Code Section 409A or, as to
ISOs, eligibility for ISO tax treatment. 
 (c) No Obligation. Notwithstanding any other provision of the Plan, any
Option Document, any Stock Appreciation Right Agreement, or terms of any Stock Award or Restricted Stock Unit the Company, any Affiliate, the Board, or any of their employees or agents, (i) shall have no obligation to take any action to prevent
the assessment of any additional income tax, excise tax or penalty on any Recipient because of Code Section 409A and (ii) shall have no such liability to any Recipient for any such taxes or penalty. 

  
 12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}]]